44P BOLD-100-001: A phase II study of BOLD-100 in combination with FOLFOX in advanced mCRC patients that have failed at least two prior lines of therapy Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • O'Kane, GM
  • Spratlin, J
  • Oh, D-Y
  • Rha, SY
  • McWhirter, Elaine
  • Elimova, E
  • Kavan, P
  • Choi, MK
  • Kim, D
  • Goodwin, RA
  • Hecht, JR
  • Koo, D-H
  • Halani, K
  • McAllister, R
  • Jones, M
  • Snow, MD
  • Lemmerick, Y
  • Spera, G
  • Pankovich, J

publication date

  • June 2024